Comparison of intravenous urapidil and oral captopril in patients with hypertensive urgencies

Journal of Human Hypertension

Volumn 20, Issue 9, 2006, Pages 707-709

  Woisetschlager C ^a   Bur, A ^a   Vlcek, M ^a   Derhaschnig, U ^a   Laggner, A N ^a   Hirschl, M M ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Central Clinicum   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; PLACEBO; URAPIDIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; CAPTOPRIL; FEMALE; HUMANS; HYPERTENSION; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PIPERAZINES;

EID: 33747665560     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002063     Document Type: Article

References (11)

1. Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: A systematic review of the literature. J Gen Intern Med 2002; 17: 937-945.
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-2572.
3. Kjeldsen SE, Farsang C, Sleigh P, Mancia G. 1999 WHO/ISH hypertension guidelines - highlights and ESH update. J Hypertens 2001; 19: 2285-2288.
4. Elliott WJ. Hypertensive emergencies. Crit Care Clin 2001; 17: 435-451.
5. Shayne PH, Pitts SR. Severely increased blood pressure in the emergency department. Ann Emerg Med 2003; 41: 513-529.
6. Hirschl MM, Seidle D, Müllner M, Kürkciyan I, Herkner H, Bur A et al. Efficacy of different antihypertensive drugs in the emergency department. J Hum Hypertens 1996; 10(Suppl 3): S143-S146.
7. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe hypertension at 33 weeks. Br J Obstet Gynecol 1993; 100: 959-961.
8. Messerli FH, Grossman E. The use of sublingual nifedipine: A continuing concern. Arch Intern Med 1999; 159: 2259-2260.
9. Zeller KR, Von Kuhnert L, Matthews C. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. Arch Intern Med 1989; 149: 2186-2189.
10. Kumar CK, Dastoor FL, Robayo JR, Razzaque MA. Side effects of diazoxide. JAMA 1976: 235: 275-276.
11. Hirschl MM, Binder M, Bur A, Herkner H, Müllner M, Woisetschläger C et al. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intens Care Med 1997; 23: 885-888.